Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adia MedADIA 14 Days Payable is 12.67 as of Mar. 2026, which is 94% below its 10-year median of 229.38. GuruFocus rates ADIA with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Adia Med ranks worse than 96.04% on this metric.
Adia Med's average Accounts Payable for the
three
months ended in Mar. 2026 was $0.02 Mil. Adia Med's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $0.11 Mil.
Hence, Adia Med's Days Payable for the
three
months ended in Mar. 2026 was 12.67.
The historical rank and industry rank for Adia Med's Days Payable or its related term are showing as below:
ADIA'
s Days Payable Range Over the Past 10 Years
Min: 2.51 Med: 229.38 Max: 456.25
Current: 6.29
During the past 2 years, Adia Med's highest Days Payable was 456.25. The lowest was 2.51. And the median was 229.38.
ADIA's Days Payable is ranked worse than 96.04% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 57.015
vs ADIA: 6.29
Adia Med's Days Payable
increased
from Mar. 2025 (7.87) to Mar. 2026 (12.67).
It may suggest that Adia Meddelayed paying its suppliers.
The historical data trend for Adia Med's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Adia Med's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adia Med Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Adia Med's Days Payable distribution charts can be found below:
* The bar in red indicates where Adia Med's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Adia Med's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adia Med (ADIA) has a Days Payable of 12.67 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Adia Med and its competitors. This is 94% below median its historical median of 229.38. Over the past decade, Adia Med's Days Payable has ranged from 2.51 to 456.25. According to the industry distribution chart, Adia Med ranks #582 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 96%.
Is Adia Med's Days Payable too high?
Adia Med's current Days Payable of 12.67 is 94% below median its 10-year median of 229.38. Over the past 10 years, this metric has ranged from a low of 2.51 to a high of 456.25. The Healthcare Providers & Services industry median Days Payable is 57.02. Adia Med's value of 12.67 is 77.8% below this industry median. Based on the distribution chart, Adia Med ranks #582 out of 606 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Adia Med has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Adia Med's Days Payable compare to GBCS and CCM?
According to the Healthcare Providers & Services industry distribution chart, Adia Med ranks #582 out of 606 companies for Days Payable. This places Adia Med in the lower half of its industry. The industry median Days Payable is 57.02. Adia Med's value of 12.67 is 77.8% below this benchmark. Historically, Adia Med's own Days Payable has ranged from 2.51 to 456.25 over the past decade. While the company's 10-year median is 229.38 vs. the industry median of 57.02, Adia Med has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.02, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adia Med's current Days Payable of 12.67 is 77.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Adia Med and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adia Med's current Days Payable is 12.67, which is 94% below median its own 10-year median of 229.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adia Med stock overvalued right now?
Adia Med (ADIA) has a current Days Payable of 12.67. The current Days Payable is 12.67, which is 94% below median its 10-year median of 229.38 and 77.8% below the Healthcare Providers & Services industry median of 57.02. Adia Med's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Adia Med (ADIA), the current Days Payable is 12.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Adia Nutrition Inc focus is to work closely with healthcare providers and health insurance companies to facilitate and provide Autologous Hematopoietic Stem Cell Transplantation (AHSCT). Its products and the deployment of the therapies utilizing its products address various orthopedic issues, pain management, and wound repair. In addition, its products are able to be utilized in various other therapies to address anti-aging issues and other tissue repair desires. It operates in three segments The Biolete segment comprises the sale of supplements; Adia Med performs stem cell treatments to patients; and Adia Labs procures and sells stem cell products to outside clinics or to Adia Med. It derives revenue from Sales of supplements, Medical procedures, Sales of biologics and ancillary products.
14GF Score
Get the complete analysis for ADIA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADIA has been successfully added to your 
